Cargando…
Polymorphisms in folate pathway and pemetrexed treatment outcome in patients with malignant pleural mesothelioma
INTRODUCTION: A combination of pemetrexed and cisplatin has been shown to improve the outcome in patients with malignant pleural mesothelioma (MPM), however, there is a great heterogeneity in treatment response among patients. The aim of our study was to evaluate the influence of polymorphisms in fo...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Versita, Warsaw
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078035/ https://www.ncbi.nlm.nih.gov/pubmed/24991206 http://dx.doi.org/10.2478/raon-2013-0086 |